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To assess  the  effectiveness  and  safety  of stentoplasty  in people  with osteoporotic  vertebral  body  fractures.
A  systematic  search  of  databases  including  MEDLINE,  EMBASE  and  Cochrane  library,  between  others,
was  conducted  to June  9, 2014.  Clinical  trials and  observational  studies  that  included  alive  adults  with
osteoporotic  vertebral  body  fractures  and  the comparators  were  the  intervention  himself,  vertebroplasty
or balloon  kyphoplasty  were  selected.  Quality  of evidence  was  graded  according  to  the  GRADE  approach.
Two review  authors  independently  selected  studies,  assessed  risk  of  bias  and  extracted  data.  Forty-two
citations  were  identiﬁed  during  the  search.  After  removing  duplicates,  ﬁve  studies were included:  two
clinical  trials  and  three  observational  studies.  Stentoplasty,  showed  higher  rate  of  adverse  events related
to material  (P  = 0.043)  and  cuff  pressure  (P = 0.014)  in  comparison  to kyphoplasty.  There  was  no  difference
between  two  procedures  in terms  of reduction  of  kyphosis,  time  of  exposure  to  radiation  or  postoperative
loss  of  cement.  Stentoplasty  in  comparison  to  vertebroplasty,  showed  an improvement  of restoration  of
vertebral  height  (P = 0.042),  kyphosis  correction  and  volume  of bone  cement.  No  differences  were found
between  two  procedures  in terms  of  loss  of  vertebral  body  volume.  Based  on  observational  studies,
stentoplasty  improved  vertebral  height,  pain  and  functional  disability  at 6  and  12  months  follow-up,  and
corrected  the  angle  vertebral  fractures  in patients  with  osteoporotic  vertebral  body.  Stentoplasty  was
presented  as  a  safe  procedure  in  short-medium  term,  with  a  low  complication  rate,  a reduced  loss of
cement  and  new  vertebral  body  fractures  lower  rates.  Stentoplasty  improves  vertebral  height,  reduces
the  pain  and  functional  disability  and  correct  the vertebral  angle  in patients  with  osteoporotic  vertebral
body  fracture  with  minimum  adverse  events.  Stentoplasty  is comparable  to kyphoplasty  in terms  of
correction  of  kyphosis,  time  of  exposure  to radiation  and  cement  postoperative  loss,  and  comparable  to
vertebroplasty  in terms  of  restoration  of vertebral  height  correction  and  bone  cement  volume.
Level  of evidence:  Level  II systematic  review.
©  2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Vertebral compression fractures (VCFs) are the most common
ype of osteoporotic fractures [1] and increases exponentially with
ge. It is estimated that VCFs occur in approximately 26% of women
ged 50 years or older [2]. In VCFs, one or more vertebrae are com-
ressed, leading to a reduction in height and potentially also to
bnormal curvature of the spine (kyphosis). In 66% of cases, the
CFs can lead to sever acute and chronic pain, impaired mobil-
ty and reduced quality of life caused by the loss of vertebral
∗ Corresponding author.
E-mail address: esther.martin.lopez.sspa@juntadeandalucia.es
J.E. Martín-López).
http://dx.doi.org/10.1016/j.otsr.2015.06.002
877-0568/© 2015 Elsevier Masson SAS. All rights reserved.body height [3]. Therefore, the goal of treatment is to relieve pain
and postural impairment caused by loss of vertebral body height
without replacing [4,5]. Non-invasive treatment (such as pain
medication, bed rest and back braces) focuses on alleviating symp-
toms and supporting the spine. However, in patients whose severe
pain does not resolve with conservative management, surgical
spinal stabilization is necessary [6,7]. The initial surgical treatment
of VCFs was  percutaneous vertebroplasty, a minimally invasive sur-
gical procedure in which bone cement is injected into a fractured
vertebra under radiological guidance using ﬂuoroscopy [8]. Verte-
broplasty stabilizes the column while increasing patient mobility
and reduces the pain associated with the fracture. However, this
procedure does not correct the deformity and kyphosis spinal com-
pression associated with morbidity [9–11]. Balloon kyphoplasty
(BK) is a variation of this approach in which an inﬂatable balloon
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amp is placed in the collapsed vertebra before cement injection
n order to create a virtual cavity allowing low-pressure cement
njection [12,13]. A potential advantage of this procedure is that it
ay partially correct the reduction in vertebral height, however the
egree of height restoration may  be none or minimal after deﬂating
he balloon [14,15].
Stentoplasty has been proposed as a new minimally invasive
herapeutic option for patients with VCFs. In this approach a small
alloon catheter surrounded by a metal stent is inserted into the
ertebral body in order to maintain the vertebral height of the cav-
ty into which bone cement is then injected. The expanded stent
rovides mechanical stability and keeps open the created cavity,
reventing the collapse of the vertebral body while the balloons
re folded and removed [6]. The average time for completion of
he procedure is about 45 minutes. The patient can be incorpo-
ated as soon as tolerated and is free to resume physical activity
s a function of the intensity of pain. One of the goals of vertebral
ody stenting was to improve patient safety and reduce the risk of
ement leakage by formation of a cavity for cement application, as
ccurs with balloon kyphoplasty. This procedure could allow ver-
ebral fractures to be fully corrected and to stop the loss of restored
ertebral body height after balloon deﬂation. However, clinical out-
omes of evidence for this procedure are variable and contradictory
nd the advantage of vertebral body stenting remains unclear, so
he optimal treatment of this patient population is still debated.
he aim of this study is to determine the clinical effectiveness and
afety of stentoplasty as a treatment for patients with osteoporotic
CFs as himself, as in comparison to vertebroplasty or balloon
yphoplasty.
. Methodology
A systematic search of databases including MEDLINE, EMBASE
nd Cochrane library, The Cochrane Central Register of Controlled
rials (CENTRAL), University of York Centre for Health technology
ssessment (INAHTA), Clinicaltrials.gov and UK National Research
egister was conducted with a cut-off date of June 9, 2014. The
earch strategies combined MeSH (Medical Subject Headings),
mtree terms and text words to deﬁne the population, index test
stentoplasty), comparator and outcomes (PICO format). Searches
ere not limited by language, date or publication type except
etters from publishers. Additionally, reference lists of the ﬁnal
election of articles were checked manually to identify other rele-
ant papers. Clinical trials (randomized or not) and observational
tudies involving more than 15 patients and including alive peo-
le of any age and either sex with painful osteoporotic vertebral
ody fractures and the comparators were the intervention him-
elf, vertebroplasty or balloon kyphoplasty were selected. Studies
hich also included participants with non-osteoporotic vertebral
ractures of other aetiologies (e.g. fractures associated with trauma,
yeloma or metastatic cancer) were included if data relating to
articipants with osteoporotic fractures could be extracted sepa-
ately, or if the proportion of participants with non-osteoporotic
ractures was extremely small (n < 5). Studies in animals models,
reclinical and biological studies, narrative reviews, editorials, sur-
eys, conference papers or series of individual cases and studies
ith modiﬁcations of the standard stentoplasty were excluded
rom the review. Titles and abstracts of all retrieved articles were
canned for inclusion by two reviewers with reference to a third
eviewer when there was any doubt about their eligibility for
eaching consensus. Primary outcomes were pain/analgesic use,
ncapacity/back-speciﬁc functional status, mortality and compli-
ations. Vertebral body height and angular deformity, incidence of
ew vertebral fractures, and cement leakage were considered as
econdary outcomes. Only studies which reported data relating togy: Surgery & Research 101 (2015) 627–632
at least one of the primary or secondary outcomes listed were eli-
gible for inclusion in the review. Full paper articles were retrieved
for further assessment and if there was  doubt regarding inclusion
from the title and abstract, the full article was  obtained for clariﬁ-
cation. The quality of the included studies was  critically assessed
by the same two  reviewers using a tool based on the criteria pro-
posed by Stevenson et al for non-experimental studies, and by the
Cochrane Collaboration for controlled trials. All information was
extracted from the articles selected by two independent review-
ers using predesigned forms speciﬁcally for this. A qualitative and
quantitative (if it was possible) synthesis was performed from the
results provided by those studies that met  the inclusion criteria
and P values < 0.05 as statistically signiﬁcant, were considered with
conﬁdence intervals at 95%. The method used for determining the
level of evidence for the outcome variable was described by GRADE
(GRADE tables available electronic annex).
3. Results
Forty-two citations were identiﬁed during the search. After
removing duplicates and applying the exclusion criteria, ﬁve stud-
ies were ﬁnally included [16–20] (Fig. 1): two  clinical trials [16,20]
(one non-randomized [16]) and three observational prospective
[18,19] and retrospective studies [17]. Clinical trials compared
stentoplasty with percutaneous balloon kyphoplasty [20] and sten-
toplasty with percutaneous vertebroplasty (n = 29) [16]. None of
included studies compared results of stentoplasty with conserva-
tive treatment or non-surgical management. Table 1 shows the
included studies description.
Included studies accounted a total of 213 symptomatic patients
(77.4% women  and 22.5% men) between 35 and 94 years of age
(mean 71.5 years). All included patients had persistent local midline
back pain refractory to conservative treatment for indetermi-
nate time and back pain related to the site of the fracture on
magnetic resonance imaging (MRI), only one study [16] included
patients with pain refractory to conservative treatment for at least
6 weeks. Description of population in included studies is presented
in Table 2. Only one study [20] deﬁned osteoporotic fractures as
fractures that occurred spontaneously or as a result of minimal
trauma from day-to-day activities, but did not it in terms of bone
mineral density. The remainder appeared to assume the presence
of osteoporosis from the presence of VCF in the absence of any other
known fracture aetiology. The procedures were performed through
a percutaneous transpedicular approach with two  stents placed
below the collapsed vertebral endplate as seen on a ﬂuoroscopic
view, except one [17] that did not inform about used method. The
included studies varied in terms of internal validity. The potential
sources of bias in case of included clinical trials were the lack of clar-
ity about the method of both assignment to treatment groups and
concealment of allocation, as only one of them [20] was reported
as randomized. Because of the radio-opaque nature of the cement
used for stentoplasty, vertebroplasty or kyphoplasty, it is impos-
sible to blind the assessors of radiographic outcomes (vertebral
body height, kyphotic angle and incident fracture) to treatment
allocation. However, there is no other reason why blinded asses-
sors should not have been used to collect data relating to other
outcomes (detection bias).
3.1. Stentoplasty versus percutaneous balloon kyphoplasty
Only one controlled trial compared the stentoplasty clini-
cal and radiological results with balloon kyphoplasty (n = 65,
100 fractures) [20] (Table 3). There was  no difference between
the two  procedures in terms of reduction of kyphosis (low qual-
ity), time of exposure to radiation or postoperative loss of cement
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Fig. 1. PRISMA ﬂow diagram.
Table 1
Description of included studies.
Study, year Study design Outcomes analyzed Country of
ﬁrst author
Sources of
funding
Comparison Duration of
follow
Number of
patients
included
Number of
patients
randomized
Recruitment
periods
Clement et al.,
2013 [21]
Randomized
clinical trial
Changes in deformity;
adverse events;
pressure balloon; loss
of cement
Switzerland None Balloon
kyphoplasty
ND 65 65 ND
Thaler et al.,
2013 [16]
No randomized
clinical trial
Vertebral height;
changes in deformity;
loss of cement
Austria ND Vertebroplasty 3.1 months 56 0 January to
November
2009
Muto  et al.,
2011 [19]
Prospective
case series
Changes in deformity;
adverse events;
pressure balloon; loss
of cement
Italy ND Stentoplasty 12 months 17 – ND
Klezl  et al.,
2011 [18]
Prospective
case series
Pain changes in
deformity; disabilities;
loss of cement
United
Kingdom
ND Stentoplasty
(traumatic and
osteoporotic
fractures)
12 months 20 – January 2009
to December
2010
Diel  et al.,
2013 [17]
Retrospective
case series
Characteristics of the
fracture;
complications; review;
reoperation;
realignment
Switzerland ND Stentoplasty ND 100 – ND
ND: undescribed.
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Table 2
Description of population in included studies.
Clinical trials Observational studies
Clement et al.,
2013 [21]
Thaler et al., 2013 [16] Klezl et al., 2011 [18] Muto et al.,
2011 [19]
Diel et al., 2013 [17]
N
Total 65 (40 women
and 60 men)
56 (49 women  and
7 men)
17 (11 women  and 6 men) 20a
(16 women
and 4 men)
100 (49 women and
51 men)
Vertebroplasty – 29
Balloon kyphoplasty 10 –
Average age in years (standard
deviation/range)
70 (± 13) 67.9 (49.2–94.6)
vertebroplasty group
66.9 (46.5–87.4)
stentoplasty group
71 75.7 66.7 (35.4–91) men
76.3 (41.1–87.1)
women
Classiﬁcation AO A1.1, A1.2,
A1.3, y A3.1
A1 A3.1 ND A1.x o A.3.1
Lesion  location ND T10-L5 ND T11 (n = 2)
T12 (n = 4)
L1 (n = 1)
L2 (n = 2)
L3 (n = 5)
L4 (n = 6)
T10-L5
Pretreatment ND Conservative treatment
for at least 6 weeks
ND Conservative
measures of
unspeciﬁed
duration
ND
Clinic Signiﬁcant pain Low back pain and
persistent local midline
for at least 6 weeks and
back pain in relation to
the fracture site
Severe pain, no root in the
vertebral midline and
exacerbated conventional to
digital palpation of the spinous
processes of the affected
vertebrae or post-traumatic pain
Persistent pain Local Lumbalgia over
4 points according EVA
and corresponding to
the fracture site
ND: undescribed; EVA: visual analog scale.
a These were only 16 patients with osteoporotic vertebral body fracture.
Table 3
Stentoplasty versus Balloon kyphoplasty (Clement et al., 2013) [21]. Results.
Outcome variable Stentoplasty Balloon Kyphoplasty P value
Effectiveness
Correction of the kyphotic angle 4.7 ± 4.2 4.5 ± 3.6 0.972
Safety
Ball  pressure (mean ± standard deviation) 348 ± 72 233 ± 81 0.014
Radiation time (mean ± standard deviation) 116 ± 42 96 ± 66 0.462
Cement loss (number of patients) 15 10 0.230
Number of complications
N lymet
(
i
r
i
c
i
3
p
o
a
i
f
b
3
s
eRelated material 9 
Total  24 
D: undescribed; TC: computed tomography; RM:  magnetic resonance; PMMA:  po
very low quality). The parameters that showed statistically signif-
cant differences between the two techniques were adverse events
elated to the material (P = 0.043) and cuff pressure (P = 0.014), both
n favour of kyphoplasty (very low quality). However, in relation to
omplications, there was no signiﬁcant difference between the two
ntervention arms after elimination of the effect of material failure.
.2. Stentoplasty versus vertebroplasty
Only one clinical trial comparing stentoplasty versus vertebro-
lasty [16] (n = 56, 55 vertebra), showed an improvement in terms
f restoration of vertebral height (P = 0.042), kyphosis correction
nd volume of bone cement necessary to perform the procedure
n favour of stentoplasty (very low quality). No differences were
ound between the two procedures in terms of loss of vertebral
ody volume during follow-up (very low quality) (Table 4).
.3. Stentoplasty: effectiveness and safety from observational
tudies
Three case series studies [17–19] were identiﬁed about
ffectiveness and safety of stentoplasty, two of them [18,19]1 0.043
11 0.013
hylmethacrylate.
retrospectively and one [17], prospectively. No data from these
studies could be pooled because of missing data and no coincidence
of follow-up time intervals. Stentoplasty, based on the identiﬁed
non-experimental studies, improved vertebral height, pain and
functional disability at 6 and 12 months follow-up, and corrected
the angle vertebral fractures in patients with osteoporotic verte-
bral body (very low quality). Regarding to the safety, stentoplasty
was presented as a safe procedure in short-medium term, with a
low complication, loss of cement and emergence of new vertebral
body fractures rates (very low quality).
4. Discussion
Based on non-experimental studies, stentoplasty has been
reported to be an effective method of improving vertebral height,
pain and functional disability at 6 and 12 months follow-up,
and correcting the angle vertebral fractures in patients with
osteoporotic vertebral body fractures. Based on unblinded non-
randomized trials, stentoplasty has shown improvements in terms
of vertebral height restoration of kyphosis and bone cement volume
required to perform the procedure compared to vertebroplasty.
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Table  4
Stentoplasty versus vertebroplasty (Thaler et al., 2013) [16]. Results.
Outcome variable Stentoplasty Vertebroplasty P value
Effectiveness
Improved vertebral height (mean ± standard
deviation)
4.024 ± 2.925 0.642 ± 2.868 < 0.001
Improved kyphotic segment
(mean ± standard deviation)
2.826 ± 4.850 1.540 ± 8.639 0.378
Improved vertebral kyphosis
(mean ± standard deviation)
0.964 ± 8.548 1.978 ± 4.731 0.042
Safety
Vertebral volume loss (cm3)
Mean (range)
0.28(0.01–1.64) 0.15
(0.01–1.8)
0.129
V omog
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a
talues are shown as means ± standard deviation. ND: undescribed; TC: computed t
linded randomized trials have shown that stentoplasty is com-
arable to kyphoplasty in terms of correction of kyphosis, time
f exposure to radiation as well as cement postoperative loss in
atients with osteoporotic vertebral body fracture, while it has
een associated with an increase in the number of complications
elated to the materials used in during the procedure.
However, these results should be interpreted with caution due
o the small number of items retrieved, the short duration of follow
p of patients and the low quality of the evidence. Other limitation
or interpretation of these ﬁndings was the use of intermediate out-
omes (as correction of the kyphotic angle, ball pressure, cement
oss, or vertebral volume loss) as main outcomes. Intermediate
utcomes measures may  be confounded by a number of factors
nd although may  also be useful clinical outcomes, back pain-
elated disability and quality of life may  provide more objective and
linically meaningful measures. There is no convincing evidence
hat some of these outcomes, as vertebral augmentation, provide
ny substantial beneﬁts above patients with osteoporotic verte-
ral body fractures. Furthermore, these outcomes were measured
n heterogeneous ways among the studies and in different follow-
p time period, so it was not possible to aggregate their ﬁndings.
nsufﬁcient evidence, particularly on the impact of stentoplasty on
rimary outcomes as quality of life, pain or mortality rates, so no
eﬁnitive conclusion can be made. The most serious methodologi-
al problem was the lack of blinding in all studies except Clement
21], because although it is impossible to blind the assessors of
adiographic ﬁndings by the radiopaque nature of the cement
sed, there seems no reason why the charge of interpreting other
utcome variables were not blinded. This is an important aspect
ecause unblinding in surgical studies has been linked to a 25%
verestimation of treatment effect [22]. This may have inﬂuenced
he results in favour of the experimental group (stentoplasty). Other
mportant topics about generalisability of results are if the age
nd sex make-up of the study samples was fairly representative
f that of the wider osteoporotic population and the missing data
egarding to the ethnic composition of studies samples. All studies
ere carried out exclusively in Europe, so the generalisability of
he ﬁndings to the other origins of populations with painful osteo-
orotic vertebral fractures is unclear.
The robustness of this review was enhanced by a compre-
ensive search strategy, including a broad search of databases
nd manual searches of the bibliographies of retrieved studies.
urthermore, two reviewers independently undertook data extrac-
ion, assessment of quality according to the GRADE approach
nd study inclusion. The assessment of clinical effectiveness and
afety included data from randomized controlled trials (RCTs),
on-randomized studies, and case series. Clinical trials are not a
ood source of evidence when assessing adverse events because
hey usually do not have sufﬁcient capacity to reliably detect rare
dverse events or the follow-up period is usually long enough
o allow detection of adverse events that occur long after theraphy; RM:  magnetic resonance; PMMA:  polymethylmethacrylate.
operation is performed. Furthermore, often clinical trials do not
always measure all potential side effects. Therefore, it was decided
to include in the review safety observational studies with more
than 15 patients. The decision to establish the number of patients
reﬂects a desire to exclude small series of cases that could show a
high rate of adverse events associated with limited experience of
the intervention. Up to this moment, this is the only analysis con-
ducted comparing results from stentoplasty with vertebroplasty
and kyphoplasty in patients with osteoporotic vertebral body frac-
tures.
Others aspects needed for consider utility of stentoplasty are
the costs or safety-related topics derived from procedure perfor-
mance. One of RCTs included [23], examined the costs of conducting
the stentoplasty versus kyphoplasty in patients with osteoporotic
vertebral body fractures. On the date and place of conducting this
study, Switzerland, 2010, the costs associated with material used
to deal with stentoplasty a single vertebral level was  approxi-
mately 4735.5 D (3750 $), while the associated kyphoplasty in the
same conditions was about 6692.9 D (6950 $). When treatment
was applied to three vertebral levels in the same patient, stento-
plasty costs amounted to 13,133.3 D (10,400 $) and approximately
7955.7 D (6300 $) for balloon kyphoplasty. There has been some
discussion over the past decade concerning the risk to staff per-
forming vertebroplasty, kyphoplasty and stentoplasty procedures
of radiation exposure. Although this risk is low, is of potential
importance. For example, Harstall et al. [24] estimated an annual
risk of 0.0025% for fatal cancer of the thyroid, and a risk of develop-
ing any cancer of 0.025%. However, these risks can be somewhat
mitigated by following a number of precautionary measures [25].
Finally, more research based on RCT, with higher samples and
with longer follow-up time period is needed for knowing effec-
tiveness and safety of stentoplasty in patients with osteoporotic
vertebral body fractures.
5. Conclusion
Low and very low quality evidence support that stento-
plasty improves vertebral height, reduces the pain and functional
disability at 6 and 12 months follow-up, and corrects the verte-
bral angle in patients with osteoporotic vertebral body fracture.
Regarding safety is a safe procedure at short-medium term, not
associated with serious adverse events. Stentoplasty is comparable
to kyphoplasty in terms of correction of kyphosis, time of expo-
sure to radiation as well as cement postoperative loss in patients
with osteoporotic vertebral body fracture, while it has been asso-
ciated with an increase in the number of complications related to
the materials used in during the procedure. Compared to vertebro-
plasty, stentoplasty has shown improvements in terms of vertebral
height restoration of kyphosis and bone cement volume required
to perform the procedure.
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